Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.

COVID-19 Louisiana SARS-CoV-2 United States coronavirus disease coronaviruses correctional facilities detention facilities respiratory infections serial testing severe acute respiratory syndrome coronavirus 2 transmission viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 5 1 2021
medline: 3 2 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

To assess transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a detention facility experiencing a coronavirus disease outbreak and evaluate testing strategies, we conducted a prospective cohort investigation in a facility in Louisiana, USA. We conducted SARS-CoV-2 testing for detained persons in 6 quarantined dormitories at various time points. Of 143 persons, 53 were positive at the initial test, and an additional 58 persons were positive at later time points (cumulative incidence 78%). In 1 dormitory, all 45 detained persons initially were negative; 18 days later, 40 (89%) were positive. Among persons who were SARS-CoV-2 positive, 47% (52/111) were asymptomatic at the time of specimen collection; 14 had replication-competent virus isolated. Serial SARS-CoV-2 testing might help interrupt transmission through medical isolation and quarantine. Testing in correctional and detention facilities will be most effective when initiated early in an outbreak, inclusive of all exposed persons, and paired with infection prevention and control.

Identifiants

pubmed: 33395380
doi: 10.3201/eid2702.204158
pmc: PMC7853536
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-429

Références

MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):594-598
pubmed: 32407301
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):836-840
pubmed: 32614816
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1139-1143
pubmed: 32817597
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Clin Infect Dis. 2007 Oct 15;45(8):1047-55
pubmed: 17879924
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):523-526
pubmed: 32352954
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
JAMA Intern Med. 2020 Aug 1;180(8):1041-1042
pubmed: 32343355
MMWR Morb Mortal Wkly Rep. 2020 Aug 11;69(32):1095-1099
pubmed: 32790655
Emerg Infect Dis. 2020 Oct;26(10):2401-2405
pubmed: 32610037
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
JAMA. 2020 Aug 11;324(6):602-603
pubmed: 32639537
Clin Infect Dis. 2020 Jun 21;:
pubmed: 32562541
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH